NXGL
HealthcareNexgel Inc
$0.60+0.01 (+1.59%)LIVE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving NXGL Today?
No stock-specific AI insight has been generated for NXGL yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Market Cap$5M
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume76K
Avg Volume (10D)—
Shares Outstanding8.5M
NXGL News
20 articles- NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of DirectorsYahoo Finance·May 6, 2026
- NEXGEL Appoints Ian Blackman as Chief Financial OfficerYahoo Finance·Apr 27, 2026
- NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease SegmentYahoo Finance·Apr 21, 2026
- Celularity Announces Closing of Transaction with NexGelYahoo Finance·Apr 21, 2026
- NEXGEL, Inc. Q4 2025 Earnings Call SummaryMoby·Apr 21, 2026
- NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ETGlobeNewswire Inc.·Apr 17, 2026
- NEXGEL Reschedules Shareholder Update Conference Call to April 23rd at 4:30 P.M. ET to Provide Update on Celularity TransactionYahoo Finance·Apr 15, 2026
- NexGel Inc (NXGL) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Operational ...Yahoo Finance·Apr 9, 2026
- NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity TransactionYahoo Finance·Apr 8, 2026
- NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with CelularityYahoo Finance·Mar 31, 2026
- NEXGEL to Report Fourth Quarter and Full Year 2025 Financial Results on March 31stYahoo Finance·Mar 25, 2026
- NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial ProductsYahoo Finance·Mar 12, 2026
- Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product OpportunitiesYahoo Finance·Mar 12, 2026
- NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial ProductsYahoo Finance·Mar 10, 2026
- NEXGEL Announces Financing of $1.797 Million Relating to an Acquisition Targeted to Close in the First Quarter of 2026, Subject to the Completion of Due DiligenceYahoo Finance·Feb 10, 2026
- NEXGEL, Inc.'s (NASDAQ:NXGL) Shift From Loss To ProfitYahoo Finance·Dec 22, 2025
- NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic AdvisorYahoo Finance·Dec 16, 2025
- NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRxYahoo Finance·Dec 11, 2025
- NexGel Inc (NXGL) Q3 2025 Earnings Call Highlights: Progress Towards Profitability Amidst ...Yahoo Finance·Nov 12, 2025
- NEXGEL Reports Third Quarter 2025 Financial ResultsYahoo Finance·Nov 11, 2025
All 20 articles loaded
Price Data
Open$0.00
Previous Close$0.59
Day High$0.00
Day Low$0.00
52 Week High—
52 Week Low—
Fundamentals
Market Cap$5M
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume76K
Avg Volume (10D)—
Shares Outstanding8.5M
About Nexgel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
HealthcareSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Company Details
Security TypeStock
ExchangeNASDAQ
Currency—
Round Lot—
SICSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CIK—
Composite FIGI—
Share Class FIGI—